Article

Levodopa and dopamine dynamics in Parkinson’s disease metabolomics

2018-04-23

Abstract excerpt

Parkinson’s disease (PD) is a progressive neurological disorder caused by a combination of genetic and environmental factors. Metabolomics is a powerful tool that can be used to screen for potential biomarkers, exogenous toxicants, and metabolic network changes associated with disease states. Here, we used high-resolution metabolomics to compare over 10,000 plasma metabolic features from older adults with and with...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 33478bc7-d9a3-54c6-a5b5-fa2affc5db93
DOI: 10.1101/306266

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Levodopa and dopamine dynamics in Parkinson’s disease metabolomicsDOI 10.1101/306266Read

The role of dopaminergic medication, lipid, and endocannabinoid pathway alterations in idiopathic and<i>PRKN/PINK1</i>-mediated Parkinson’s disease – a large-scale targeted metabolomics studySemantic proximity Read

Brain-wide transcriptome-based metabolic alterations in Parkinson’s disease: human inter-region and human-experimental model correlationsSemantic proximity Read

Multi-Omic Analysis Reveals Lipid Dysregulation Associated with Mitochondrial Dysfunction in Parkinson’s Disease BrainSemantic proximity Read

Untargeted Plasma Metabolomics Unveils Distinct Metabolite Profiles in Parkinson’s Disease Subtypes: A Focus on idiopathic REM Sleep Behavior DisordersSemantic proximity Read

A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot studySemantic proximity Read

Biomarker Research in Parkinson’s Disease Using Metabolite ProfilingSemantic proximity Read

Untargeted <sup>1</sup> H NMR-based metabolomics reveal sex-based differences in blood metabolome profiles among patients with Parkinson’s disease, regardless of their idiopathic or genetic subtypeSemantic proximity Read

Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease.Semantic proximity Read

Metabolomics of blood reveals age-dependent pathways in Parkinson’s DiseaseSemantic proximity Read

Exploring the interplay between metabolomics and genetics in Parkinson's disease: Insights from ongoing research and future avenuesSemantic proximity Read

Metabolic profiling of CSF from people suffering from Sporadic and LRRK2 Parkinson’s disease: a pilot study.Semantic proximity Read

Metabolic Profiling of CSF from People Suffering from Sporadic and LRRK2 Parkinson's Disease: A Pilot Study.Semantic proximity Read